Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FL75V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,215
Award facts
- Contract value 100% obligated
- $12,214.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,214.89 for Zepbound 2.5 mg/0.5 mL pens on September 12, 2025, with a completion date of September 15, 2025. This firm fixed-price, competitively awarded contract represents a non-set-aside procurement and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is issued as a child order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts with the DLA and serves critical supply functions for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's established relationship with the Defense Logistics Agency and demonstrated capability to deliver specialized pharmaceuticals—including diabetes medications, neurological treatments, and other therapeutic products—positions it as a key vendor within the military healthcare supply chain. This delivery order for Zepbound, a GLP-1 receptor agonist diabetes medication, reflects the ongoing federal demand for pharmaceutical commodities supporting military personnel and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FL75V?
SPE2DB25FL75V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FL75V worth?
The government has obligated $12,215 on SPE2DB25FL75V.
Is contract SPE2DB25FL75V an order under another contract?
Yes. SPE2DB25FL75V is a delivery order under SPE2DB20D2002, an indefinite delivery contract.
Was contract SPE2DB25FL75V competed?
The extent of competition for SPE2DB25FL75V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award